This collaborative webinar between Children’s Hospital of Philadelphia (CHOP) and Chulalongkorn University (Thailand) reviews core principles of adolescent development and how neurobiological and psychosocial changes contribute to vulnerability to mental health problems. This includes providing a structured approach to universal and targeted screening using tools such as the PHQ-9 and protocols for risk assessment (including suicidality). Case studies and discussions from Thailand, the United States, and Botswana illustrate real-world implementation, cross-cultural considerations, and the role of primary pediatric providers in detection, brief intervention, and referral. This session emphasizes feasible strategies for low-resource and high-volume clinics and highlights opportunities for quality improvement and innovation in adolescent mental health care.
Learning Objectives:
- Describe key stages of adolescent development and their implications for mental health risk and resilience
- Apply brief validated tools (e.g., PHQ-9) and structured protocols to screen adolescents for depression and suicide risk in routine care
- Implement practical strategies to create a youth-friendly, non-judgmental environment that supports disclosure of mental health concerns and engagement in care
- Use case-based learning to adapt integrated mental health models to their own clinical and cultural context.
Subject Matter Experts:
-
- Renata Arrington-Sanders, MD, MPH, ScM
- Nadvadee Aungkawattanapong, MD
- Wipaporn Natalie Songtaweesin, MD
- Merrian Brooks, DO, MS
- Ariana Rivens, PhD
This seminar focuses on adolescent medicine and was delivered for the collaborative webinar series between Children’s Hospital of Philadelphia and Chulalongkorn University, on April 10, 2025.
Content Disclaimer
The Terms of Use and Privacy Policy set forth on the website of The Children’s Hospital of Philadelphia apply to any and all uses of and access to this site and the content found here.
The work presented in the presentations, videos, and other content on this site (“Presentations”) includes publicly available medical evidence, a consensus of medical practitioners, and/or opinions of individual practitioners that may differ from consensus opinions. These Presentations are intended only to provide general information and need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, the availability of various resources at the health care institution where the patient is located, and other factors. The Presentations are not intended to constitute medical advice or treatment, nor should they be relied upon as such. The Presentations are not intended to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia, its physicians and the individual patients in question. The information contained in these Presentations are general in nature, and do not and are not intended to refer to specific patients.
CHOP, The Children’s Hospital of Philadelphia Foundation and its or their affiliates, the authors, presenters, practitioners, editors, and others associated with the creation of the Presentations (“CHOP”) are not responsible for errors or omissions in the Presentations; for any outcomes a patient might experience where a clinician reviewed one or more such Presentations in connection with providing care for that patient; and/or for any and all third party content on the site or in the Presentations. CHOP makes no warranty, expressed or implied, with respect to the currency, completeness, applicability or accuracy of the Presentations. Application of the information in or to a particular situation remains the professional responsibility of the practitioner who is directly treating the patient.
To the extent that the Presentations include information regarding drug dosing, in view of ongoing research, changes in government regulations and the constant flow of information relating to drug therapy and drug reactions, the viewer should not rely on the Presentation content, but rather is urged to check the package insert for each drug for indications, dosage, warnings and precautions.
Some drugs and medical devices presented in the Presentations have United States Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the practitioner to ascertain the FDA status of each drug or device planned for use in their clinical practice.
You shall indemnify, defend and hold harmless CHOP, The Children’s Hospital of Philadelphia Foundation, and its/their current and former employees, officers, and agents, trustees, and their respective successors, heirs and assigns (“Indemnitees”) against any claims, liability, damage, loss or expenses (including attorneys’ fees and expenses of litigation) in connection with any claims, suits, actions, demands or judgments arising directly or indirectly out of your reference to or use of the Presentations.
The Presentations are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Presentations may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.
By starting this module, you agree to our Content Disclaimer and Terms of Service.
Course Includes
- 1 Lesson
- Course Certificate